BIOCEPT, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 1 rows in 2023. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-06-20: Reporting owner Walsh Robert; Form 3; Security Employee Stock option (right to buy); Transaction Holding.
- 2022-11-17: Reporting owner DAO-HADDOCK QUYEN THI; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-07-08: Reporting owner Chandler Marsha Alpert; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-07-08: Reporting owner Rubinstein Linda M; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-06-20 holding as of filing | Walsh Robert Officer (VP, Controller) | 3 | Employee Stock option (right to buy) Derivative · Direct | Holding | $30.90 exercise price | 2023-06-20 |